IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT

被引:706
|
作者
FURITSU, T
TSUJIMURA, T
TONO, T
IKEDA, H
KITAYAMA, H
KOSHIMIZU, U
SUGAHARA, H
BUTTERFIELD, JH
ASHMAN, LK
KANAYAMA, Y
MATSUZAWA, Y
KITAMURA, Y
KANAKURA, Y
机构
[1] OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
[2] OSAKA UNIV,SCH MED,DEPT PATHOL,SUITA,OSAKA 565,JAPAN
[3] OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN
[4] MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN 55905
[5] HANSON CTR CANC RES,LEUKAEMIA RES UNIT,ADELAIDE,SOUTH AFRICA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1993年 / 92卷 / 04期
关键词
PROTOONCOGENE C-KIT; POINT MUTATION; LEUKEMIA; TYROSINE KINASE; ACTIVATION;
D O I
10.1172/JCI116761
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.
引用
收藏
页码:1736 / 1744
页数:9
相关论文
共 50 条
  • [11] BIOLOGICAL-ACTIVITY OF MAST-CELL GROWTH-FACTOR (MGF), A LIGAND FOR THE C-KIT PROTOONCOGENE AND PRODUCT OF THE MURINE SILOCUS
    LYMAN, SD
    WILLIAMS, DE
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (01) : 132 - 133
  • [12] EXPRESSION, FUNCTION AND ACTIVATION OF THE PROTOONCOGENE C-KIT PRODUCT IN HUMAN LEUKEMIA-CELLS
    KANAKURA, Y
    IKEDA, H
    KITAYAMA, H
    SUGAHARA, H
    FURITSU, T
    LEUKEMIA & LYMPHOMA, 1993, 10 (1-2) : 35 - 41
  • [13] Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells
    Ohmori, Keitaro
    Kawarai, Shinpei
    Yasuda, Nobutaka
    Tanaka, Akane
    Matsuda, Hiroshi
    Nishimura, Ryohei
    Sasaki, Nobuo
    Tsujimoto, Hajime
    Masuda, Kenichi
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 126 (1-2) : 43 - 53
  • [14] Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
    Joris, Magalie
    Georgin-Lavialle, Sophie
    Chandesris, Marie-Olivia
    Lhermitte, Ludovic
    Claisse, Jean-Francois
    Canioni, Danielle
    Hanssens, Katia
    Damaj, Gandhi
    Hermine, Olivier
    Hamidou, Andmohammed
    CASE REPORTS IN HEMATOLOGY, 2012, 2012
  • [15] EFFECTS OF HUMAN RECOMBINANT C-KIT RECEPTOR LIGAND, RHSCF, ON HUMAN LUNG MAST-CELL HETEROGENEITY
    BRIDGES, M
    SCHULMAN, ES
    VALLOROSI, C
    POST, TJ
    CLINICAL RESEARCH, 1993, 41 (02): : A368 - A368
  • [16] THE ROLE OF C-KIT AND ITS LIGAND, STEM-CELL FACTOR, IN MAST-CELL APOPTOSIS
    MEKORI, YA
    OH, CK
    METCALFE, DD
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 136 - 138
  • [17] PROLIFERATION OF HUMAN MYELOID-LEUKEMIA CELL-LINE ASSOCIATED WITH THE TYROSINE-PHOSPHORYLATION AND ACTIVATION OF THE PROTOONCOGENE C-KIT PRODUCT
    KURIU, A
    IKEDA, H
    KANAKURA, Y
    GRIFFIN, JD
    DRUKER, B
    YAGURA, H
    KITAYAMA, H
    ISHIKAWA, J
    NISHIURA, T
    KANAYAMA, Y
    YONEZAWA, T
    TARUI, S
    BLOOD, 1991, 78 (11) : 2834 - 2840
  • [18] THE RAT C-KIT LIGAND, STEM-CELL FACTOR, INDUCES C-KIT RECEPTOR-DEPENDENT MOUSE MAST-CELL ACTIVATION INVIVO - EVIDENCE THAT SIGNALING THROUGH THE C-KIT RECEPTOR CAN INDUCE EXPRESSION OF CELLULAR FUNCTION
    WERSHIL, BK
    TSAI, M
    GEISSLER, EN
    ZSEBO, KM
    GALLI, SJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01): : 245 - 255
  • [19] THE C-KIT LIGAND, STEM-CELL FACTOR, PROMOTES MAST-CELL SURVIVAL BY SUPPRESSING APOPTOSIS
    IEMURA, A
    TSAI, M
    ANDO, A
    WERSHIL, BK
    GALLI, SJ
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 144 (02): : 321 - 328
  • [20] Non c-Kit Tyrosine Kinase Expression In Mast Cell Leukemia
    Butterfield, Joseph H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB57 - AB57